Bryan Dulhunty
Chief Financial Officer
life science
Benitec Biopharma
Australia
Biography
Bryan brings a unique set of skills and experience to life science companies. Bryan is a qualified Chartered Accountant who has been heavily involved in the life science industry for nearly 20 years. His previous roles cover positions such as Executive Chairman, Managing Director, CEO, Company Secretary and CFO of numerous listed and non listed life science companies. ​Educated at Sydney University (Economics degree), Bryan became a Chartered Accountant while working with Ernst and Young while maintaining a strong interest in science. Bryan then made the move to the commercial world by joining one of the worlds largest multinational companies. Wanting to have a greater input on decision making, Bryan entered the world of Australian small start up companies. Bryan's passion lay with life science, hence the formation of CoSA in 2000. Bryan soon developed an extensive client base including being invited to become a director of a number of listed and unlisted public companies. In 2005 Bryan was invited to take on the role of Executive Chairman to restructure a listed biotech with significant governance issues. Over the next 7 years under Bryan's leadership the Company prospered. Its research was developed from the pre-clinical stage to FDA approved Phase II trials in the USA. Bryan’s involvement with the Company ended in mid 2012 leaving it with a strong cash position having raised over $40m, a strong patent position, strong product development plan and the strong support of shareholders. Bryan re-established CoSA as a boutique service provider to the life science community bringing a unique and broad set of skills and experience.
Research Interest
Bryan brings a unique set of skills and experience to life science companies. Bryan is a qualified Chartered Accountant who has been heavily involved in the life science industry for nearly 20 years. His previous roles cover positions such as Executive Chairman, Managing Director, CEO, Company Secretary and CFO of numerous listed and non listed life science companies
